Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Shortt, J.
1714  Ergebnisse:
Personensuche X
?
1

EFFICACY AND SAFETY OF LUSPATERCEPT VERSUS EPOETIN ALFA IN ..:

Garcia-Manero, G. ; Platzbecker, U. ; Santini, V....
Leukemia Research Reports.  21 (2024)  - p. 100447 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Encouraging complete responses (CRs) with CDK9 inhibitor AZ..:

Zinzani, P. L. ; Feldman, T. ; Collins, G....
Hematological Oncology.  41 (2023)  S2 - p. 568-569 , 2023
Link: https://doi.org/10.1002/..
 
?
3

AFM13 IN PATIENTS WITH CD30 POSITIVE RELAPSED OR REFRACTORY..:

Kim, W. S. ; Shortt, J. ; Zinzani, P. L....
Hematological Oncology.  41 (2023)  S2 - p. 195-196 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Radiotherapy (RT) & Durvalumab in Relapsed/Refractory Diffu..:

Hawkes, E. A. ; Palmer, J. ; Chong, G....
Hematological Oncology.  41 (2023)  S2 - p. 599-600 , 2023
Link: https://doi.org/10.1002/..
 
?
5

P720: PROACTIVE DASATINIB DOSE REDUCTION IN THE ALLG CML 12..:

Yeung, D. ; Grigg, A. ; Shanmuganathan, N....
HemaSphere.  6 (2022)  - p. 615-616 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P1261: ALLG LABORATORY SCIENCE STUDY LS21: MOLECULAR CORREL..:

Tatarczuch, M. ; Waltham, M. ; Shortt, J....
HemaSphere.  6 (2022)  - p. 1146-1147 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENT..:

Gill, H. ; Yacoub, A. ; Pettit, K....
HemaSphere.  6 (2022)  - p. 941-942 , 2022
Link: https://doi.org/10.1097/..
 
?
8

P590: PRELIMINARY SAFETY AND EFFICACY OF BGB-11417, A POTEN..:

Shortt, J. ; Tan, S. Y. ; Cannell, P....
HemaSphere.  6 (2022)  - p. 489-490 , 2022
Link: https://doi.org/10.1097/..
 
?
9

P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOME..:

Palandri, F. ; Ross, D. M. ; Cochrane, T....
HemaSphere.  6 (2022)  - p. 923-924 , 2022
Link: https://doi.org/10.1097/..
 
?
10

P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPRO..:

Shaw, B. ; Shortt, J. ; Rogers, B....
HemaSphere.  6 (2022)  - p. 1490-1491 , 2022
Link: https://doi.org/10.1097/..
 
?
11

Substituted 1-methyl-4-phenylpyrrolidin-2-ones – Fragment-b..:

Hilton-Proctor, J.P. ; Ilyichova, O. ; Zheng, Z....
European Journal of Medicinal Chemistry.  191 (2020)  - p. 112120 , 2020
Link: https://doi.org/10.1016/..
 
?
12

ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATI..:

Gregory, G. ; Walker, P. ; Mahadevan, D....
Hematological Oncology.  37 (2019)  S2 - p. 328-329 , 2019
Link: https://doi.org/10.1002/..
 
?
13

R‐IVAC SALVAGE THERAPY IN RELAPSED AND REFRACTORY DLBCL:

Casan, J. ; Wolyncewicz, G. ; Alam, W....
Hematological Oncology.  37 (2019)  S2 - p. 435-436 , 2019
Link: https://doi.org/10.1002/..
 
?
14

Synthesis and elaboration of N-methylpyrrolidone as an acet..:

Hilton-Proctor, J.P. ; Ilyichova, O. ; Zheng, Z....
Bioorganic & Medicinal Chemistry.  27 (2019)  24 - p. 115157 , 2019
Link: https://doi.org/10.1016/..
 
?
15

'Do you need a kayak to learn outside?': a literature revie..:

Hawxwell, L. ; O'Shaughnessy, M. ; Russell, C..
Education 3-13.  47 (2018)  3 - p. 322-332 , 2018
Link: https://doi.org/10.1080/..
 
1-15